| First Author | Lee JY | Year | 2023 |
| Journal | PLoS One | Volume | 18 |
| Issue | 8 | Pages | e0285159 |
| PubMed ID | 37540725 | Mgi Jnum | J:340695 |
| Mgi Id | MGI:7515817 | Doi | 10.1371/journal.pone.0285159 |
| Citation | Lee JY, et al. (2023) PHRF1 promotes the class switch recombination of IgA in CH12F3-2A cells. PLoS One 18(8):e0285159 |
| abstractText | PHRF1 is an E3 ligase that promotes TGF-beta signaling by ubiquitinating a homeodomain repressor TG-interacting factor (TGIF). The suppression of PHRF1 activity by PML-RARalpha facilitates the progression of acute promyelocytic leukemia (APL). PHRF1 also contributes to non-homologous end-joining in response to DNA damage by linking H3K36me3 and NBS1 with DNA repair machinery. However, its role in class switch recombination (CSR) is not well understood. In this study, we report the importance of PHRF1 in IgA switching in CH12F3-2A cells and CD19-Cre mice. Our studies revealed that Crispr-Cas9 mediated PHRF1 knockout and shRNA-silenced CH12F3-2A cells reduced IgA production, as well as decreased the amounts of PARP1, NELF-A, and NELF-D. The introduction of PARP1 could partially restore IgA production in PHRF1 knockout cells. Intriguingly, IgA, as well as IgG1, IgG2a, and IgG3, switchings were not significantly decreased in PHRF1 deficient splenic B lymphocytes isolated from CD19-Cre mice. The levels of PARP1 and NELF-D were not decreased in PHRF1-depleted primary splenic B cells. Overall, our findings suggest that PHRF1 may modulate IgA switching in CH12F3-2A cells. |
